TAIKO PHARMACEUTICAL CO., LTD. (4574) Cash flow
Market cap
¥15.4B
P/E ratio
27.8x
Makes over-the-counter medicines like Seirogan and Cleverin infection control products, serving consumers and institutions across Japan and Asia.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 281 | 351 | 445 | 454 | 461 | 495 | 473 | 941 | 737 | 704 | 256 | 265 |
| Cash from operations | 690 | 378 | 2,698 | -60 | 1,748 | 3,493 | -1,517 | -1,595 | -1,994 | -307 | 362 | 814 |
| Capital expenditures | -2,881 | -3,718 | -112 | -129 | -303 | -157 | -2,145 | -1,476 | -64 | -97 | -157 | -291 |
| Cash from investing | -2,755 | -2,636 | -72 | -114 | -747 | -448 | -2,760 | -1,622 | 190 | 1,166 | -5 | 142 |
| Payments for dividends | -325 | -320 | -196 | -283 | -499 | -499 | -846 | -782 | - | -1 | -1 | - |
| Repurchases of common stock | -642 | -0 | - | - | -0 | -540 | -0 | - | - | - | - | - |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | 5,000 | - | 500 | - | - |
| Repayments of term debt | - | - | - | - | - | - | - | -316 | -923 | -1,053 | -1,206 | -1,206 |
| Cash from financing | -825 | -136 | 1,249 | -74 | -338 | -581 | -649 | 3,959 | -997 | 1,539 | -1,181 | -1,227 |